(Q35191412)

7 August 2017

title

Postantibiotic effect of fidaxomicin and its major metabolite, OP-1118, against Clostridium difficile (English)

1 reference

7 August 2017

main subject

Clostridium difficile

0 references

author name string

Farah Babakhani

1

1 reference

7 August 2017

Abraham Gomez

2

1 reference

7 August 2017

Nikki Robert

3

1 reference

7 August 2017

Pamela Sears

4

1 reference

7 August 2017

language of work or name

English

0 references

publication date

27 June 2011

1 reference

Antimicrobial Agents and Chemotherapy

7 August 2017

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

7 August 2017

volume

55

1 reference

7 August 2017

issue

9

1 reference

7 August 2017

page(s)

4427-4429

1 reference

Fidaxomicin versus vancomycin for Clostridium difficile infection

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165303

Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165303

Clostridium difficile infection: new developments in epidemiology and pathogenesis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165303

OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165303

In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165303

Safety, tolerance, and pharmacokinetic studies of OPT-80 in healthy volunteers following single and multiple oral doses

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165303

In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165303

Alternative treatments for Clostridium difficile disease: what really works?

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165303

In vitro activities of OPT-80 and comparator drugs against intestinal bacteria

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165303

Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165303

In vitro activity of OPT-80 against Clostridium difficile

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165303

Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165303

A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165303

Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21709084

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00104-11

1 reference

7 August 2017

1 reference

7 August 2017

1 reference